Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1975 Jan;37(1):101–104. doi: 10.1136/hrt.37.1.101

Endocarditis caused by Rhodotorula successfully treated with 5-fluorocytosine.

Y Naveh, A Friedman, D Merzbach, N Hashman
PMCID: PMC484161  PMID: 1167783

Abstract

A 7-year-old boy suffering from aortic regurgitation and mitral stenosis and regurgitation was admitted with endocarditis caused by Rhodotorula pilimanae and was treated successfully with orally administered antifungal agent, namely 5-fluorocytosine (5-FC). A dose of 100 mg per kg body weight, divided into four equal parts, was prescribed. After a prolonged febrile period his temperature dropped to normal on the fourth day of 5-FC therapy. Review of the published reports disclosed few cases of endocarditis due to Rhodotorula spp. and this case seems to be the first treated with 5-FC. Follow-up in one year, after discharge from the hospital, revealed no evidence of relapse.

Full text

PDF
101

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cherubin C. E., Neu H. C. Infective endocarditis at the Presbyterian Hospital in New York City from 1938-1967. Am J Med. 1971 Jul;51(1):83–96. doi: 10.1016/0002-9343(71)90326-3. [DOI] [PubMed] [Google Scholar]
  2. Fass R. J., Perkins R. L. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses. Ann Intern Med. 1971 Apr;74(4):535–539. doi: 10.7326/0003-4819-74-4-535. [DOI] [PubMed] [Google Scholar]
  3. Isacson M., Noah Z., Faber J., Herishano Y., Gottfried L. Use of 5-fluorocytosine in systemic candidiasis in infancy. Arch Dis Child. 1972 Dec;47(256):954–959. doi: 10.1136/adc.47.256.954. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. LOURIA D. B., GREENBERG S. M., MOLANDER D. W. Fungemia caused by certain nonpathogenic strains of the family Cryptococcaceae. Report of two cases due to Rhodotorula and Torulopsis glabrata. N Engl J Med. 1960 Dec 22;263:1281–1284. doi: 10.1056/NEJM196012222632504. [DOI] [PubMed] [Google Scholar]
  5. Leeber D. A., Scher I. Rhodotorula fungemia presenting as "endotoxic" shock. Arch Intern Med. 1969 Jan;123(1):78–81. [PubMed] [Google Scholar]
  6. Record C. O., Skinner J. M., Sleight P., Speller D. C. Candida endocarditis treated with 5-fluorocytosine. Br Med J. 1971 Jan 30;1(5743):262–264. doi: 10.1136/bmj.1.5743.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SHELBURNE P. F., CAREY R. J. Rhodotorula fungemia complicating staphylococcal endocarditis. JAMA. 1962 Apr 7;180:38–42. doi: 10.1001/jama.1962.03050140040009. [DOI] [PubMed] [Google Scholar]
  8. Steer P. L., Marks M. I., Klite P. D., Eickhoff T. C. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience. Ann Intern Med. 1972 Jan;76(1):15–22. doi: 10.7326/0003-4819-76-1-15. [DOI] [PubMed] [Google Scholar]
  9. Tassel D., Madoff M. A. Treatment of Candida sepsis and Cryptococcus meningitis with 5-fluorocytosine. A new antifungal agent. JAMA. 1968 Oct 21;206(4):830–832. [PubMed] [Google Scholar]
  10. Utz J. P. Flucytosine. N Engl J Med. 1972 Apr 6;286(14):777–778. doi: 10.1056/NEJM197204062861412. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES